Cargando…
Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells
The eradication of cancer stem cells (CSCs) is vital to successful cancer treatment and overall disease-free survival. CSCs are a sub-population of cells within a tumor that are defined by their capacity for continuous self-renewal and recapitulation of new tumors, demonstrated in vitro through sphe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572370/ https://www.ncbi.nlm.nih.gov/pubmed/37834020 http://dx.doi.org/10.3390/ijms241914577 |
_version_ | 1785120219229847552 |
---|---|
author | Fernando, Wasundara Clark, Rikki F. Rupasinghe, H. P. Vasantha Hoskin, David W. Coombs, Melanie R. Power |
author_facet | Fernando, Wasundara Clark, Rikki F. Rupasinghe, H. P. Vasantha Hoskin, David W. Coombs, Melanie R. Power |
author_sort | Fernando, Wasundara |
collection | PubMed |
description | The eradication of cancer stem cells (CSCs) is vital to successful cancer treatment and overall disease-free survival. CSCs are a sub-population of cells within a tumor that are defined by their capacity for continuous self-renewal and recapitulation of new tumors, demonstrated in vitro through spheroid formation. Flavonoids are a group of phytochemicals with potent anti-oxidant and anti-cancer properties. This paper explores the impact of the flavonoid precursor phloridzin (PZ) linked to the ω-3 fatty acid docosahexaenoate (DHA) on the growth of MCF-7 and paclitaxel-resistant MDA-MB-231-TXL breast cancer cell lines. Spheroid formation assays, acid phosphatase assays, and Western blotting were performed using MCF-7 cells, and the cell viability assays, Annexin-V-488/propidium iodide (PI) staining, and 7-aminoactinomycin D (7-AAD) assays were performed using MDA-MB-231-TXL cells. PZ-DHA significantly reduced spheroid formation, as well as the metabolic activity of MCF-7 breast cancer cells in vitro. Treatment with PZ-DHA also suppressed the metabolic activity of MDA-MB-231-TXL cells and led to apoptosis. PZ-DHA did not have an observable effect on the expression of the drug efflux transporters ATP-binding cassette super-family G member 2 (ABCG2) and multidrug resistance-associated protein 1 (MRP1). PZ-DHA is a potential treatment avenue for chemo-resistant breast cancer and a possible novel CSC therapy. Future pre-clinical studies should explore PZ-DHA as a chemo-preventative agent. |
format | Online Article Text |
id | pubmed-10572370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105723702023-10-14 Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells Fernando, Wasundara Clark, Rikki F. Rupasinghe, H. P. Vasantha Hoskin, David W. Coombs, Melanie R. Power Int J Mol Sci Article The eradication of cancer stem cells (CSCs) is vital to successful cancer treatment and overall disease-free survival. CSCs are a sub-population of cells within a tumor that are defined by their capacity for continuous self-renewal and recapitulation of new tumors, demonstrated in vitro through spheroid formation. Flavonoids are a group of phytochemicals with potent anti-oxidant and anti-cancer properties. This paper explores the impact of the flavonoid precursor phloridzin (PZ) linked to the ω-3 fatty acid docosahexaenoate (DHA) on the growth of MCF-7 and paclitaxel-resistant MDA-MB-231-TXL breast cancer cell lines. Spheroid formation assays, acid phosphatase assays, and Western blotting were performed using MCF-7 cells, and the cell viability assays, Annexin-V-488/propidium iodide (PI) staining, and 7-aminoactinomycin D (7-AAD) assays were performed using MDA-MB-231-TXL cells. PZ-DHA significantly reduced spheroid formation, as well as the metabolic activity of MCF-7 breast cancer cells in vitro. Treatment with PZ-DHA also suppressed the metabolic activity of MDA-MB-231-TXL cells and led to apoptosis. PZ-DHA did not have an observable effect on the expression of the drug efflux transporters ATP-binding cassette super-family G member 2 (ABCG2) and multidrug resistance-associated protein 1 (MRP1). PZ-DHA is a potential treatment avenue for chemo-resistant breast cancer and a possible novel CSC therapy. Future pre-clinical studies should explore PZ-DHA as a chemo-preventative agent. MDPI 2023-09-26 /pmc/articles/PMC10572370/ /pubmed/37834020 http://dx.doi.org/10.3390/ijms241914577 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Fernando, Wasundara Clark, Rikki F. Rupasinghe, H. P. Vasantha Hoskin, David W. Coombs, Melanie R. Power Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells |
title | Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells |
title_full | Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells |
title_fullStr | Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells |
title_full_unstemmed | Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells |
title_short | Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells |
title_sort | phloridzin docosahexaenoate inhibits spheroid formation by breast cancer stem cells and exhibits cytotoxic effects against paclitaxel-resistant triple negative breast cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572370/ https://www.ncbi.nlm.nih.gov/pubmed/37834020 http://dx.doi.org/10.3390/ijms241914577 |
work_keys_str_mv | AT fernandowasundara phloridzindocosahexaenoateinhibitsspheroidformationbybreastcancerstemcellsandexhibitscytotoxiceffectsagainstpaclitaxelresistanttriplenegativebreastcancercells AT clarkrikkif phloridzindocosahexaenoateinhibitsspheroidformationbybreastcancerstemcellsandexhibitscytotoxiceffectsagainstpaclitaxelresistanttriplenegativebreastcancercells AT rupasinghehpvasantha phloridzindocosahexaenoateinhibitsspheroidformationbybreastcancerstemcellsandexhibitscytotoxiceffectsagainstpaclitaxelresistanttriplenegativebreastcancercells AT hoskindavidw phloridzindocosahexaenoateinhibitsspheroidformationbybreastcancerstemcellsandexhibitscytotoxiceffectsagainstpaclitaxelresistanttriplenegativebreastcancercells AT coombsmelanierpower phloridzindocosahexaenoateinhibitsspheroidformationbybreastcancerstemcellsandexhibitscytotoxiceffectsagainstpaclitaxelresistanttriplenegativebreastcancercells |